DEA Proposes Putting Three Fentanyl-Related Substances in Schedule I
Published Date: 6/10/2025
Proposed Rule
Summary
The DEA wants to make three specific fentanyl-related drugs officially illegal by putting them in Schedule I, which means super strict rules and penalties for anyone making, selling, or using them. This change affects drug makers, researchers, and law enforcement, and aims to keep communities safer by stopping dangerous substances. You’ve got until July 10, 2025, to share your thoughts before the new rules lock in.
Analyzed Economic Effects
4 provisions identified: 1 benefits, 3 costs, 0 mixed.
Possession or Handling Without Registration Becomes Illegal
If you make, distribute, import, export, engage in research with, or possess para-bromofentanyl, para-fluoroacetyl fentanyl, or para-methyl acetyl fentanyl without required DEA registration, you would be subject to the administrative, civil, and criminal sanctions that apply to Schedule I controlled substances.
Researchers and Labs Face Schedule I Rules
If you handle para-bromofentanyl, para-fluoroacetyl fentanyl, or para-methyl acetyl fentanyl for research, you must be registered with DEA and follow Schedule I requirements. That includes initial inventories when you first handle the substances, taking a new inventory every two years, meeting Schedule I security standards, complying with labeling and packaging rules, and maintaining required records and reports.
Manufacturers and Distributors Must Follow Quotas and Orders
If you manufacture or distribute any of the three named fentanyl-related substances you must be a DEA registrant and may only manufacture in accordance with a DEA-assigned quota. Distributors must comply with Schedule I order form requirements and submit required reports (including reports to the Automation of Reports and Consolidated Order System) as specified by DEA regulations.
Scheduling Aimed at Reducing Public Health Risk
DEA found para-bromofentanyl, para-fluoroacetyl fentanyl, and para-methyl acetyl fentanyl pose risks to public health (e.g., DEA-TOX identified para-fluoroacetyl fentanyl in six cases and para-bromofentanyl in two cases; NFLIS reported 112 reports for para-fluoroacetyl and para-methyl acetyl fentanyl between 2022 and 2024). Making these substances permanently Schedule I is proposed to continue controls intended to limit their illicit availability and associated overdose risks.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2025-05007, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Starting December 31, 2025, veterans can get buprenorphine treatment and follow-up care through telemedicine, making it easier to access help for opioid use disorder without leaving home. This change affects veterans using VA health services and aims to improve treatment access while the government reviews feedback and policies. No new costs are mentioned, but the delay gives agencies time to ensure the rules work well.
2025-02793, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
The government is giving veterans easier access to buprenorphine treatment through telemedicine, letting them get care remotely. This change affects veterans using VA health services and aims to make treatment smoother and more convenient. The new rules were supposed to start February 18, 2025, but now they’ll kick in on March 21, 2025, while the government gathers public feedback.
2026-21799, Vida Janson, M.D.; Decision and Order
Vida Janson, M.D., lost her license to handle controlled substances in Washington State, so the DEA has officially revoked her registration to prescribe or dispense these drugs. This means she can no longer legally work with controlled substances, effective immediately. If you’re a healthcare provider or patient in Washington, this change ensures only authorized professionals handle these medications.
2026-21725, Barry Backiewicz, D.D.S.; Decision and Order
Dr. Barry Backiewicz from Ohio lost his DEA registration because he no longer has permission to handle controlled substances in his state. He didn’t ask for a hearing to challenge this, so the decision to revoke his registration is final. This means he can’t legally prescribe or manage controlled drugs anymore, effective immediately.
Previous / Next Documents
Previous: 2025-10294, Endangered and Threatened Wildlife and Plants; Two Species Not Warranted for Listing as Endangered or Threatened Species
The U.S. Fish and Wildlife Service reviewed two cave critters—the cannulate cave isopod and the Dry Fork Valley cave beetle—and decided they don’t need endangered or threatened status right now. This means no new protections or costs will kick in, but the public can still share new info anytime. The decision was made official on June 10, 2025.
Next: 2025-10422, Amendment of Class D and Class E5 Airspace; Revocation of Class E4 Airspace Dover, DE
The FAA wants to update the airspace rules around Dover Air Force Base, Delaware, to make flying safer and clearer for pilots using instruments. They’re changing some airspace boundaries, removing outdated zones, and updating location info for Dover’s airports and navigation aids. If you have thoughts, speak up by July 25, 2025—no costs or delays expected for the public.